The CTIG haplotype of VEGF −2578C/A, −7C/T, −2549I/D, and −1001G/C polymorphisms was associated with increased risk of bladder cancer [64] whereas TACI haplotype of VEGF +936C/T, −1154G/A, −2578C/A and −2549I/D polymorphisms was associated with increased risk of end stage renal disease [65]. Here, VEGFA is linked to urinary bladder carcinoma.